Strumento inattivo

Azioni Ambrx Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Ambrx : Innovative Antibody Drug Conjugate (ADC) US IND Active	17/08/16
Ambrx : closes $45M round of financing	04/08/16
Ambrx : Announces New Chief Medical Officer	16/11/15
Ambrx : Names Dr. Tiecheng Qiao as CEO, Dr. Feng Tian as CSO	19/06/15
Ambrx : Chinese Consortium Enters into Agreement to Acquire Ambrx	19/06/15

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,73 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd